title: Novel genome polymorphisms in BCG vaccine strains and impact on efficacy.
abstract: Bacille Calmette-Guérin (BCG) is an attenuated strain of Mycobacterium bovis currently used as a vaccine against tuberculosis. Global distribution and propagation of BCG has contributed to the in vitro evolution of the vaccine strain and is thought to partially account for the different outcomes of BCG vaccine trials. Previous efforts by several molecular techniques effectively identified large sequence polymorphisms among BCG daughter strains, but lacked the resolution to identify smaller changes. In this study, we have used a NimbleGen tiling array for whole genome comparison of 13 BCG strains. Using this approach, in tandem with DNA resequencing, we have identified six novel large sequence polymorphisms including four deletions and two duplications in specific BCG strains. Moreover, we have uncovered various polymorphisms in the phoP-phoR locus. Importantly, these polymorphisms affect genes encoding established virulence factors including cell wall complex lipids, ESX secretion systems, and the PhoP-PhoR two-component system. Our study demonstrates that major virulence factors are different among BCG strains, which provide molecular mechanisms for important vaccine phenotypes including adverse effect profile, tuberculin reactivity and protective efficacy. These findings have important implications for the development of a new generation of vaccines.
authors.affiliation: Department of Molecular Genetics, University of Toronto, 1 King's College Circle, Toronto, Ontario, Canada. andreas.leung@utoronto.ca
authors.forename: Andrea S
authors.initials: AS
authors.lastname: Leung
authors.forename: Vanessa
authors.initials: V
authors.lastname: Tran
authors.forename: Zuowei
authors.initials: Z
authors.lastname: Wu
authors.forename: Xuping
authors.initials: X
authors.lastname: Yu
authors.forename: David C
authors.initials: DC
authors.lastname: Alexander
authors.forename: George Fu
authors.initials: GF
authors.lastname: Gao
authors.forename: Baoli
authors.initials: B
authors.lastname: Zhu
authors.forename: Jun
authors.initials: J
authors.lastname: Liu
mesh_terms: D001500:BCG Vaccine / Q000235:genetics*; D016678:Genome; D016680:Genome, Bacterial; D009169:Mycobacterium tuberculosis / Q000235:genetics; D020411:Oligonucleotide Array Sequence Analysis; D010641:Phenotype; D011110:Polymorphism, Genetic; D016896:Treatment Outcome; D014376:Tuberculosis / Q000382:microbiology* / Q000517:prevention & control* / Q000628:therapy; D014774:Virulence / Q000235:genetics
chemical_list: D001500:BCG Vaccine
references.citation: Proc IEEE Comput Syst Bioinform Conf. 2004;:69-79
references.pmid: 16448001
references.citation: Bull World Health Organ. 1976;53(4):435-43
references.pmid: 1086736
references.citation: FEBS Lett. 2006 Oct 2;580(22):5328-38
references.pmid: 16979633
references.citation: Lancet. 2006 Apr 8;367(9517):1173-80
references.pmid: 16616560
references.citation: Infect Immun. 2003 Mar;71(3):1134-40
references.pmid: 12595424
references.citation: Nature. 1998 Jun 11;393(6685):537-44
references.pmid: 9634230
references.citation: Yeast. 2000 Jun 30;17(2):111-23
references.pmid: 10900457
references.citation: Vet Microbiol. 2008 Jun 22;129(3-4):333-41
references.pmid: 18207337
references.citation: Infect Immun. 2005 Apr;73(4):2190-6
references.pmid: 15784562
references.citation: Infect Immun. 1998 May;66(5):2221-9
references.pmid: 9573111
references.citation: JAMA. 1994 Mar 2;271(9):698-702
references.pmid: 8309034
references.citation: Nat Rev Microbiol. 2007 Nov;5(11):883-91
references.pmid: 17922044
references.citation: Indian J Dermatol Venereol Leprol. 2007 Mar-Apr;73(2):86-93
references.pmid: 17456912
references.citation: Bull World Health Organ. 1974;51(5):489-94
references.pmid: 4549499
references.citation: Adv Tuberc Res. 1984;21:107-93
references.pmid: 6475644
references.citation: Infect Immun. 1996 Jan;64(1):1-9
references.pmid: 8557324
references.citation: Vaccine. 2007 Jun 11;25(24):4659-64
references.pmid: 17498852
references.citation: J Appl Bacteriol. 1992 Feb;72(2):126-33
references.pmid: 1313411
references.citation: Microbiology (Reading). 1999 Jul;145 ( Pt 7):1695-1701
references.pmid: 10439408
references.citation: Cell Host Microbe. 2008 Feb 14;3(2):97-103
references.pmid: 18312844
references.citation: Tubercle. 1983 Sep;64(3):223-4
references.pmid: 6636307
references.citation: J Bacteriol. 2008 Feb;190(4):1317-28
references.pmid: 18065544
references.citation: BMC Evol Biol. 2006 Nov 15;6:95
references.pmid: 17105670
references.citation: Vaccine. 2006 Apr 24;24(17):3408-19
references.pmid: 16564606
references.citation: PLoS Pathog. 2008 Feb 8;4(2):e33
references.pmid: 18282096
references.citation: Clin Infect Dis. 2000 Sep;31 Suppl 3:S64-7
references.pmid: 11010824
references.citation: Nature. 1999 Nov 4;402(6757):79-83
references.pmid: 10573420
references.citation: Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3147-52
references.pmid: 11880648
references.citation: Vaccine. 2007 Nov 23;25(48):8114-22
references.pmid: 17954004
references.citation: Stud Hist Philos Biol Biomed Sci. 2005 Dec;36(4):696-721
references.pmid: 16337557
references.citation: Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5596-601
references.pmid: 17372194
references.citation: Nat Med. 2007 Mar;13(3):286-7
references.pmid: 17342140
references.citation: Vaccine. 1999 Feb 26;17(7-8):915-22
references.pmid: 10067698
references.citation: Nucleic Acids Res. 2003 Apr 1;31(7):e35
references.pmid: 12655023
references.citation: Nat Med. 2003 May;9(5):533-9
references.pmid: 12692540
references.citation: Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11562-7
references.pmid: 17609386
references.citation: Genome Res. 2000 Dec;10(12):2044-54
references.pmid: 11116098
references.citation: Vaccine. 2004 Jul 29;22(21-22):2675-80
references.pmid: 15309814
references.citation: Nat Rev Microbiol. 2006 Jun;4(6):469-76
references.pmid: 16710326
references.citation: Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13853-8
references.pmid: 11095745
references.citation: Infect Immun. 2005 Aug;73(8):4676-83
references.pmid: 16040980
references.citation: Control Clin Trials. 1994 Aug;15(4):247-76
references.pmid: 7956266
references.citation: Genome Res. 2002 Nov;12(11):1749-55
references.pmid: 12421762
references.citation: Nature. 2004 Sep 2;431(7004):84-7
references.pmid: 15343336
references.citation: Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7877-82
references.pmid: 12788972
references.citation: Antimicrob Agents Chemother. 2006 Aug;50(8):2836-41
references.pmid: 16870781
references.citation: Clin Infect Dis. 2001 Jan;32(1):159-61
references.pmid: 11112675
references.citation: J Clin Microbiol. 2004 Jan;42(1):212-9
references.pmid: 14715755
references.citation: J Biol Stand. 1975;3(4):349-52
references.pmid: 1102547
references.citation: Mol Microbiol. 2006 Nov;62(3):667-79
references.pmid: 17076665
references.citation: Wkly Epidemiol Rec. 2004 Jan 23;79(4):27-38
references.pmid: 14768305
references.citation: J Bacteriol. 2005 Apr;187(7):2267-77
references.pmid: 15774869
references.citation: J Bacteriol. 2008 Feb;190(4):1329-34
references.pmid: 18065542
references.citation: Science. 1999 May 28;284(5419):1520-3
references.pmid: 10348738
references.citation: Bull World Health Organ. 1990;68(1):93-108
references.pmid: 2189588
references.citation: Infect Immun. 2003 Apr;71(4):1672-9
references.pmid: 12654780
references.citation: Biochemistry. 2007 Dec 25;46(51):14751-61
references.pmid: 18052041
references.citation: J Biol Stand. 1976;4(4):319-27
references.pmid: 791950
references.citation: Genome Res. 2004 Mar;14(3):398-405
references.pmid: 14993206
references.citation: Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):431-6
references.pmid: 16387854
references.citation: Microbiology (Reading). 1996 Nov;142 ( Pt 11):3135-45
references.pmid: 8969511
references.citation: Lancet Infect Dis. 2002 Feb;2(2):86-92
references.pmid: 11901655
references.citation: Prog Lipid Res. 2005 Sep;44(5):259-302
references.pmid: 16115688
references.citation: Pediatrics. 1995 Jul;96(1 Pt 1):29-35
references.pmid: 7596718
references.citation: J Bacteriol. 1996 Mar;178(5):1274-82
references.pmid: 8631702
references.citation: J Biol Chem. 2006 Jan 20;281(3):1313-6
references.pmid: 16326699
references.citation: Vaccine. 2006 Mar 6;24(10):1593-600
references.pmid: 16257099
references.citation: Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1530-4
references.pmid: 7878014
references.citation: Bull Int Union Tuberc Lung Dis. 1988 Jun;63(2):47-59
references.pmid: 3066422
references.citation: Infect Immun. 2002 Feb;70(2):672-8
references.pmid: 11796598
references.citation: Vaccine. 2003 Oct 1;21(27-30):4270-4
references.pmid: 14505909
references.citation: Tuber Lung Dis. 1999;79(4):243-50
references.pmid: 10692993
references.citation: Expert Opin Biol Ther. 2008 Feb;8(2):201-11
references.pmid: 18194076
references.citation: Tubercle. 1983 Mar;64(1):1-13
references.pmid: 6342243
references.citation: Clin Infect Dis. 1995 Jan;20(1):126-35
references.pmid: 7727638
references.citation: Mol Microbiol. 2006 Apr;60(2):312-30
references.pmid: 16573683